B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

WEE1

MOLECULAR TARGET

WEE1 G2 checkpoint kinase

UniProt: AAH70052NCBI Gene: 746528 compounds

WEE1 (WEE1 G2 checkpoint kinase) is targeted by 28 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting WEE1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tozasertib4.3375
2bosutinib4.0858
3midostaurin3.8546
4neratinib3.6638
5nintedanib3.6136
6pelitinib3.5032
7tae 6843.4330
8fedratinib3.4029
9dovitinib3.0921
10lestaurtinib3.0420
11adavosertib3.0420
12pf 037583093.0019
13volasertib2.9418
14r 4062.8316
15pd 01662852.8316
16milciclib2.7715
17kw 24492.6413
18defactinib2.4811
19aee 7882.309
20su 0148132.208
21cyc 1162.087
22pf 038147351.795
23ucn 011.795
24Fluocinonide0.691
25indirubin0.691
26Pemoline0.691
27Sulfaguanidine0.691
28Ursodeoxycholic Acid0.691

About WEE1 as a Drug Target

WEE1 (WEE1 G2 checkpoint kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 28 compounds with documented WEE1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

WEE1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.